Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Cell Stem Cell
|
July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
Priscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Targeted Oncology
|
February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Radiation Oncology (London, England)
|
February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer
Paula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Cell Stem Cell
|
May 14, 2019
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration
Brian J Pepe-Mooney, Michael T Dill, Anna Alemany, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 14, 2011
Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients
Katharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 18, 2009
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction
A A C M Heestermans, J W Van Werkum, C Hamm, et al.
Heart (British Cardiac Society)
|
October 22, 2010
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial
R S Hermanides, A A C M Heestermans, J M Ten Berg, et al.
BMJ Open
|
September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)
Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
Hepatology (Baltimore, Md.)
|
July 16, 2015
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
Patricia Marti, Claudia Stein, Tanja Blumer, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort
Najib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Cell Stem Cell
|
July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
Priscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Targeted Oncology
|
February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Radiation Oncology (London, England)
|
February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer
Paula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Cell Stem Cell
|
May 14, 2019
Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration
Brian J Pepe-Mooney, Michael T Dill, Anna Alemany, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 14, 2011
Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients
Katharina Baur, Joachim C Mertens, Johannes Schmitt, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 18, 2009
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction
A A C M Heestermans, J W Van Werkum, C Hamm, et al.
Heart (British Cardiac Society)
|
October 22, 2010
High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trial
R S Hermanides, A A C M Heestermans, J M Ten Berg, et al.
BMJ Open
|
September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)
Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
Hepatology (Baltimore, Md.)
|
July 16, 2015
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
Patricia Marti, Claudia Stein, Tanja Blumer, et al.
Alimentary Pharmacology & Therapeutics
|
April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal Cohort
Najib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Page
of 8